The emergence of drug resistant HIV variants and novel anti-retroviral therapy

After its identification in 1980s, HIV has infected more than 30 million people the era of highly active anti-retroviral therapy, anti-retroviral drug resistanc ew roerslduwltisd efr.o Imn isnuspupfofircti ethnet aindteia- rtehtarot vainratil- prreetrsosvuirrea,l wdhriucgh rmesaiys talenacde thoa tsr eeavtomlveendt flaairlguerely. Parse lai mreinsuarlty osft uldowie-s wadohrledr;e hnocwe eovfe rp,a ati ehnigtsh ltyo htehteerraopgye naenodu se hxtoerndsei voef vuisrael oqfu aansit-i-srpeetcroievsi raarle d cruurgrse nitnl yt hceir cduelvaetilnogp eidn ddeifvfeerloepnitn cgo nnastiidoenrsi.n Tg htuhse, tvhaer ypirnigo raitniztii-ngre otrfo svtirraatel gdireusg a dreospitsetdan icne s upcrehv tawleon wcoer. ldIns sthhiosu ladr tbicel eq,u witee ecxopulnotrreie ds,i fafesr tehnecye rse ipnr easnetni-t rtewtoro dviisratiln dcrt uegc orelosgisictaanl cnei cphaetste orfn Hs IbVe tfwroemen a dne evveololupteiodn aanryd sdteavnedlpoopiinntg

HIV infection, Evolution, Drug resistance